- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Trader extraordinaire Mike Sassano may be in Russia.
Scott Sacane had claimed he bought shares by mistake.
The Laureate deal shows the appeal of private equity.
Steel Partners keeps most of its stake in the porn player.
KKR's move shows a once-shady practice is going mainstream.
Krawcheck's move shows the burden of the position.
The reinsurance IPO shares an adviser with a huge hedge fund.
A botched buyout brings a former Goldman banker a huge payday.
Nardelli is gone, but an unresponsive board remains.
Stapled financing is fueling buyouts and conflict-of-interest allegations.